{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:27:33Z","timestamp":1769761653437,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1124\/mol.112.082891","type":"journal-article","created":{"date-parts":[[2013,1,25]],"date-time":"2013-01-25T03:15:43Z","timestamp":1359083743000},"page":"835-847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["A Novel Metabotropic Glutamate Receptor 5 Positive Allosteric Modulator Acts at a Unique Site and Confers Stimulus Bias to mGlu5 Signaling"],"prefix":"10.1016","volume":"83","author":[{"given":"M.J.","family":"Noetzel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.J.","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.N.","family":"Vinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.T.","family":"Manka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.R.","family":"Stauffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.W.","family":"Lindsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.M.","family":"Niswender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.J.","family":"Conn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.112.082891_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature10658","article-title":"Mutations causing syndromic autism define an axis of synaptic pathophysiology","volume":"480","author":"Auerbach","year":"2011","journal-title":"Nature"},{"key":"10.1124\/mol.112.082891_bib2","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1523\/JNEUROSCI.20-21-07871.2000","article-title":"Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus","volume":"20","author":"Awad","year":"2000","journal-title":"J Neurosci"},{"key":"10.1124\/mol.112.082891_bib3","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/npp.2009.30","article-title":"mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning","volume":"34","author":"Ayala","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/mol.112.082891_bib4","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1124\/mol.110.068882","article-title":"Quantitative analysis reveals multiple mechanisms of allosteric modulation of the mGlu5 receptor in rat astroglia","volume":"79","author":"Bradley","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.082891_bib5","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1124\/mol.107.040097","article-title":"N-4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptors","volume":"73","author":"Chen","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.082891_bib6","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1124\/mol.106.032425","article-title":"Interaction of novel positive allosteric modulators of metabotropic glutamate receptor 5 with the negative allosteric antagonist site is required for potentiation of receptor responses","volume":"71","author":"Chen","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.082891_bib7","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.112.082891_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2760","article-title":"Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders","volume":"8","author":"Conn","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/mol.112.082891_bib9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1124\/mol.111.074765","article-title":"Cinnabarinic acid, an endogenous metabolite of the kynurenine pathway, activates type 4 metabotropic glutamate receptors","volume":"81","author":"Fazio","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.082891_bib10","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1073\/pnas.0304699101","article-title":"Heptahelical domain of metabotropic glutamate receptor 5 behaves like rhodopsin-like receptors","volume":"101","author":"Goudet","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.112.082891_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuropharm.2010.07.007","article-title":"Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential","volume":"60","author":"Gregory","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.112.082891_bib12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1124\/mol.112.080531","article-title":"Investigating mGlu5 allosteric modulator cooperativity, affinity and agonism: enriching structure-function studies and structure-activity relationships","volume":"82","author":"Gregory","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.082891_bib13","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1021\/cn100051m","article-title":"Discovery of a novel chemical class of mGlu(5) allosteric ligands with distinct modes of pharmacology","volume":"1","author":"Hammond","year":"2010","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/mol.112.082891_bib14","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/ncomms2045","article-title":"Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome","volume":"3","author":"Jung","year":"2012","journal-title":"Nat Commun"},{"key":"10.1124\/mol.112.082891_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuropharm.2010.07.010","article-title":"Allosteric modulation of G protein-coupled receptors: a pharmacological perspective","volume":"60","author":"Keov","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.112.082891_bib16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1124\/jpet.104.079244","article-title":"A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models","volume":"313","author":"Kinney","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.112.082891_bib17","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.bmcl.2010.11.119","article-title":"Discovery of molecular switches within the ADX-47273 mGlu5 PAM scaffold that modulate modes of pharmacology to afford potent mGlu5 NAMs, PAMs and partial antagonists","volume":"21","author":"Lamb","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/mol.112.082891_bib18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0026-895X(25)10255-1","article-title":"Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors","volume":"48","author":"Lazareno","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.082891_bib19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.tips.2007.06.004","article-title":"Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology","volume":"28","author":"Leach","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.112.082891_bib20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1124\/jpet.108.136580","article-title":"ADX47273 [S-(4-fluoro-phenyl)-3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities","volume":"327","author":"Liu","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.112.082891_bib21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic glutamate receptors: physiology, pharmacology, and disease","volume":"50","author":"Niswender","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/mol.112.082891_bib22","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1124\/mol.107.041053","article-title":"A novel assay of Gi\/o-linked G protein-coupled receptor coupling to potassium channels provides new insights into the pharmacology of the group III metabotropic glutamate receptors","volume":"73","author":"Niswender","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.082891_bib23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/mol.109.058768","article-title":"Context-dependent pharmacology exhibited by negative allosteric modulators of metabotropic glutamate receptor 7","volume":"77","author":"Niswender","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.082891_bib24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1124\/mol.111.075184","article-title":"Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system function","volume":"81","author":"Noetzel","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.082891_bib25","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/jpet.103.061747","article-title":"A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain","volume":"309","author":"O\u2019Brien","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.112.082891_bib26","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1016\/j.bmcl.2012.06.094","article-title":"N-Aryl pyrrolidinonyl oxadiazoles as potent mGluR5 positive allosteric modulators","volume":"22","author":"Packiarajan","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/mol.112.082891_bib27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1471-4159.1998.71020603.x","article-title":"Phosphorylation of mitogen-activated protein kinase in cultured rat cortical glia by stimulation of metabotropic glutamate receptors","volume":"71","author":"Peavy","year":"1998","journal-title":"J Neurochem"},{"key":"10.1124\/mol.112.082891_bib28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0306-4522(01)00297-4","article-title":"Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons","volume":"106","author":"Pisani","year":"2001","journal-title":"Neuroscience"},{"key":"10.1124\/mol.112.082891_bib29","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/cercor\/bhq093","article-title":"Involvement of the metabotropic glutamate receptor mGluR5 in NMDA receptor-dependent, learning-facilitated long-term depression in CA1 synapses","volume":"21","author":"Popkirov","year":"2011","journal-title":"Cereb Cortex"},{"key":"10.1124\/mol.112.082891_bib30","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1124\/mol.110.067207","article-title":"Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activity","volume":"78","author":"Rodriguez","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.082891_bib31","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1124\/mol.105.016139","article-title":"A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators","volume":"68","author":"Rodriguez","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.082891_bib32","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1021\/jm900654c","article-title":"Discovery of molecular switches that modulate modes of metabotropic glutamate receptor subtype 5 (mGlu5) pharmacology in vitro and in vivo within a series of functionalized, regioisomeric 2- and 5-(phenylethynyl)pyrimidines","volume":"52","author":"Sharma","year":"2009","journal-title":"J Med Chem"},{"key":"10.1124\/mol.112.082891_bib33","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1016\/j.bmcl.2008.05.091","article-title":"Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffold","volume":"18","author":"Sharma","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/mol.112.082891_bib34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.neuropharm.2008.06.047","article-title":"Allosteric potentiators of metabotropic glutamate receptor subtype 1a differentially modulate independent signaling pathways in baby hamster kidney cells","volume":"55","author":"Sheffler","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.112.082891_bib35","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1016\/j.bmcl.2012.04.112","article-title":"Development of a novel, CNS-penetrant, metabotropic glutamate receptor 3 (mGlu3) NAM probe (ML289) derived from a closely related mGlu5 PAM","volume":"22","author":"Sheffler","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/mol.112.082891_bib36","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1021\/cn2000519","article-title":"Progress toward positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGlu(5))","volume":"2","author":"Stauffer","year":"2011","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/mol.112.082891_bib37","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.bmcl.2011.01.027","article-title":"Discovery of novel positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5)","volume":"21","author":"Varnes","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/mol.112.082891_bib38","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.neuropharm.2011.05.005","article-title":"Metabotropic glutamate receptors as therapeutic targets for schizophrenia","volume":"62","author":"Vinson","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.112.082891_bib39","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1021\/bi200129s","article-title":"\u201cMolecular switches\u201d on mGluR allosteric ligands that modulate modes of pharmacology","volume":"50","author":"Wood","year":"2011","journal-title":"Biochemistry"},{"key":"10.1124\/mol.112.082891_bib40","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1124\/jpet.105.090308","article-title":"Allosteric potentiators of metabotropic glutamate receptor subtype 5 have differential effects on different signaling pathways in cortical astrocytes","volume":"315","author":"Zhang","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.112.082891_bib41","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.bmcl.2006.11.081","article-title":"Challenges in the development of mGluR5 positive allosteric modulators: the discovery of CPPHA","volume":"17","author":"Zhao","year":"2007","journal-title":"Bioorg Med Chem Lett"}],"updated-by":[{"DOI":"10.1124\/mol.113.10er13","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000}}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24119128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24119128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.112.082891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T09:12:04Z","timestamp":1740042724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24119128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0026895X24119128"],"URL":"https:\/\/doi.org\/10.1124\/mol.112.082891","relation":{"erratum":[{"id-type":"doi","id":"10.1124\/mol.113.10er13","asserted-by":"object"}]},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Novel Metabotropic Glutamate Receptor 5 Positive Allosteric Modulator Acts at a Unique Site and Confers Stimulus Bias to mGlu5 Signaling","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.112.082891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}